FDA Proposes Changes to Over-the-Counter Nasal Decongestant and Weight Control Products Containing Phenylpropanolamine

Summary

The FDA is issuing a notice of proposed rulemaking for over-the-counter nasal decongestant and weight control products containing phenylpropanolamine, reclassifying them from Category I to Category II status due to safety concerns. The decision follows new data and information on the safety of phenylpropanolamine.